Clinical Trial Update: Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy

View source ↗

Summary

A terminated University of Wisconsin trial examined pharmacodynamic biomarkers of standard anti-microtubule chemotherapy in early tumor biopsies for breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Breast Cancer, Breast Neoplasms | Status: TERMINATED